GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Resmed Inc. (RMD) [hlAlert]

Rating:
Underweight
RMD
up 3.07 %

Resmed Inc. (RMD) rated Underweight with price target $52 by Barclays

Posted on: Tuesday,  Jan 19, 2016  1:25 PM ET by Barclays

Barclays rated Underweight Resmed Inc. (NYSE: RMD) on 01/19/2016, when the stock price was $53.24. Since
then, Resmed Inc. has lost 2.99% as of 01/22/2016's recent price of $51.65.
If you would have followed this Barclays's recommendation on RMD, you would have gained 3.07% of your investment in 3 days.

ResMed Inc. is a holding company. Through its subsidiaries, the Company develops, manufactures and distributes medical equipment for treating, diagnosing and managing sleep-disordered breathing (SDB) and other respiratory disorders, including obstructive sleep apnea (OSA). It has developed nasal continuous positive airway pressure (CPAP) as a non-invasive treatment for OSA. CPAP systems deliver pressurized air, typically through a nasal mask, to prevent collapse of the upper airway during sleep. The Company has developed a number of products for SDB and other respiratory disorders, including airflow generators, diagnostic products, mask systems, headgear and other accessories. ResMed Inc. sells its products in over 70 countries through a combination of wholly owned subsidiaries and independent distributors to sleep clinics, home healthcare dealers and third-party payers. On April 30, 2009, it acquired Respicure Medsys PVT.LTD. In October 2009, ResMed Inc. acquired Laboratoires Narval.

Barclays
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/19/2016 1:25 PM Sell
None
53.24 52.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy